GPT Healthcare Ltd
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
- Market Cap ₹ 1,162 Cr.
- Current Price ₹ 142
- High / Low ₹ 192 / 126
- Stock P/E 27.9
- Book Value ₹
- Dividend Yield 1.76 %
- ROCE 23.6 %
- ROE 28.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 53.9%
Cons
- Promoter holding has decreased over last 3 years: -34.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| 212 | 243 | 337 | |
| 176 | 194 | 263 | |
| Operating Profit | 36 | 49 | 74 |
| OPM % | 17% | 20% | 22% |
| 4 | 6 | 5 | |
| Interest | 14 | 14 | 11 |
| Depreciation | 11 | 12 | 14 |
| Profit before tax | 15 | 29 | 54 |
| Tax % | 26% | 27% | 23% |
| 11 | 21 | 42 | |
| EPS in Rs | 6.11 | 11.76 | 5.22 |
| Dividend Payout % | -0% | 47% | 115% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 102% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 80 |
| Reserves | 109 | 116 | 78 |
| 157 | 166 | 96 | |
| 25 | 18 | 70 | |
| Total Liabilities | 308 | 317 | 323 |
| 226 | 220 | 220 | |
| CWIP | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| 80 | 97 | 92 | |
| Total Assets | 308 | 317 | 323 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| 41 | 43 | 66 | |
| -54 | -16 | -5 | |
| 12 | -22 | -57 | |
| Net Cash Flow | -1 | 4 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Debtor Days | 30 | 26 | 15 |
| Inventory Days | 60 | 41 | 30 |
| Days Payable | 314 | 165 | 121 |
| Cash Conversion Cycle | -224 | -98 | -76 |
| Working Capital Days | -4 | 32 | 3 |
| ROCE % | 14% | 24% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14 Nov - Q2 revenue INR118.9cr, EBITDA INR24.1cr, PAT INR10.6cr; 150-bed Jamshedpur MOU for INR70cr.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
11 Nov - Audio recording of conference call on unaudited Q2/H1 results for period ended Sep 30, 2025 uploaded.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10 Nov - Newspaper Publication on Un-Audited Financial Results for Q2 & H1 FY2026 and Notice of Record Date for Interim Dividend.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
8 Nov - Q2/H1 FY26 results: H1 revenue Rs228.9cr, EBITDA Rs43cr, PAT Rs18.3cr; Re1 dividend; Chairman died Aug 17, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
8 Nov - Investor Presentation for the Q2 & H1 FY2026.
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024Transcript PPT
Business Overview:[1]
GPT Healthcare Limited operates as a key regional corporate healthcare provider in Eastern India under the ILS Hospitals brand. The organization has established 5 multi-specialty hospitals with a total capacity of 719 beds, supported by 91 full-time consultants and 570 visiting consultants.